Translational neurology bridges the gap between laboratory research and clinical application, accelerating advancements in neurological care. By transforming fundamental discoveries into practical treatments, this field addresses unmet medical needs in conditions such as Parkinson’s disease, Alzheimer’s, and spinal cord injuries. Translational Neurology emphasizes the importance of preclinical studies in developing targeted therapies, ensuring their efficacy and safety before clinical trials. Emerging technologies like gene editing and stem cell therapy are pivotal in shaping innovative approaches for neurological repair and regeneration. Collaborative efforts between researchers and clinicians foster real-world applications, ultimately enhancing patient outcomes and paving the way for groundbreaking interventions.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany